Using Latent Variables and Directly Observed Treatment to Improve the Diagnosis and Management of Depression Among Hemodialysis Patients

Trial Profile

Using Latent Variables and Directly Observed Treatment to Improve the Diagnosis and Management of Depression Among Hemodialysis Patients

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Fluoxetine (Primary)
  • Indications Depression
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2018 The treatment table has been amended to include only one arm and hence the changes in study design, planned no. of patients etc. Also the duration of the treatment has changed.
    • 02 Mar 2018 Planned number of patients changed from 216 to 96.
    • 02 Mar 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top